Zealand Pharma (Denmark) Today
| ZEAL Stock | DKK 626.00 15.00 2.45% |
Performance8 of 100
| Odds Of DistressLess than 9
|
Zealand Pharma is selling at 626.00 as of the 25th of April 2024; that is 2.45 percent up since the beginning of the trading day. The stock's open price was 611.0. Zealand Pharma has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat ok performance during the last 90 days. Equity ratings for Zealand Pharma AS are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of March 2024 and ending today, the 25th of April 2024. Click here to learn more.
Zealand Pharma AS, a biotechnology company, engages in the discovery, design, and development of peptide-based medicines in Denmark. The company was founded in 1997 and is headquartered in Copenhagen, Denmark. Zealand Pharma operates under Biotechnology classification in Denmark and is traded on Copenhagen Stock Exchange. The company has 51.28 M outstanding shares. More on Zealand Pharma AS
Moving together with Zealand Stock
| 0.69 | NOVO-B | Novo Nordisk AS | PairCorr |
| 0.61 | GMAB | Genmab AS Earnings Call This Week | PairCorr |
Moving against Zealand Stock
| 0.84 | MAERSK-B | AP Mller Earnings Call This Week | PairCorr |
| 0.82 | MAERSK-A | AP Mller | PairCorr |
| 0.8 | DNORD | Dampskibsselskabet Earnings Call Today | PairCorr |
| 0.65 | SOLAR-B | Solar AS Earnings Call This Week | PairCorr |
| 0.5 | KLEE-B | Brd Klee AS | PairCorr |
| 0.45 | LUXOR-B | Investeringsselskabet | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Zealand Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Zealand Pharma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Zealand Pharma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Zealand Pharma AS (ZEAL) is traded on Copenhagen Exchange in Denmark and employs 203 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 11.16 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Zealand Pharma's market, we take the total number of its shares issued and multiply it by Zealand Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Zealand Pharma AS operates under Healthcare sector and is part of Biotechnology industry. The entity has 51.28 M outstanding shares.
Zealand Pharma AS has accumulated about 1.28 B in cash with (1.21 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 29.66.
Check Zealand Pharma Probability Of Bankruptcy
Ownership AllocationZealand Pharma AS owns a total of 51.28 Million outstanding shares. Over half of Zealand Pharma's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that purchase positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Zealand Pharma AS. Please watch out for any change in the institutional holdings of Zealand Pharma AS as this could mean something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Zealand Ownership Details
Zealand Stock Price Odds Analysis
Contingent on a normal probability distribution, the odds of Zealand Pharma jumping above the current price in 90 days from now is about 37.12%. The Zealand Pharma AS probability density function shows the probability of Zealand Pharma stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Zealand Pharma has a beta of 0.8797. This usually means Zealand Pharma AS market returns are highly reactive to returns on the market. As the market goes up or down, Zealand Pharma is expected to follow. Additionally, zealand Pharma AS has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Zealand Pharma to move above the current price in 90 days from now is about 37.12 (This Zealand Pharma AS probability density function shows the probability of Zealand Stock to fall within a particular range of prices over 90 days) .
Zealand Pharma AS Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Zealand Pharma market risk premium is the additional return an investor will receive from holding Zealand Pharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Zealand Pharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Zealand Pharma's alpha and beta are two of the key measurements used to evaluate Zealand Pharma's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.78 | |||
| Standard Deviation | 2.37 | |||
| Variance | 5.64 | |||
| Risk Adjusted Performance | (0.14) |
Zealand Stock Against Markets
Picking the right benchmark for Zealand Pharma stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Zealand Pharma stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Zealand Pharma is critical whether you are bullish or bearish towards Zealand Pharma AS at a given time. Please also check how Zealand Pharma's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Zealand Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Analysis Now
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
| All Next | Launch Module |
Zealand Pharma Corporate Management
Elected by the shareholders, the Zealand Pharma's board of directors comprises two types of representatives: Zealand Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Zealand. The board's role is to monitor Zealand Pharma's management team and ensure that shareholders' interests are well served. Zealand Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Zealand Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Henriette Wennicke | Chief Officer | Profile | |
| Lani Morvan | Investor Officer | Profile | |
| Adam MD | Pres CEO | Profile | |
| Hanne Bak | RD Director | Profile | |
| Mads Kronborg | Head Communication | Profile | |
| Ravinder Chahil | Sr Counsel | Profile | |
| Christina Bredal | VP Organization | Profile |
How to buy Zealand Stock?
Before investing in Zealand Pharma, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Zealand Pharma. To buy Zealand Pharma stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Zealand Pharma. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Zealand Pharma stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Zealand Pharma AS stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Zealand Pharma AS stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Zealand Pharma AS, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Zealand Pharma AS?
The danger of trading Zealand Pharma AS is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Zealand Pharma is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Zealand Pharma. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Zealand Pharma AS is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zealand Pharma AS. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Complementary Tools for Zealand Stock analysis
When running Zealand Pharma's price analysis, check to measure Zealand Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zealand Pharma is operating at the current time. Most of Zealand Pharma's value examination focuses on studying past and present price action to predict the probability of Zealand Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zealand Pharma's price. Additionally, you may evaluate how the addition of Zealand Pharma to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |